News on Fludarabine_Phosphate from BioPortfolio.com http://www.BioPortfolio.com Consolidated Fludarabine_Phosphate news from BioPortfolio.com Tue, 09 Feb 2010 20:59:50 GMT en Arzerra (ofatumumab) receives positive opinion for conditional approval in Europe for refractory chronic lymphhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960729&HITNO=0&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960729&THISHREF=http://c.moreover.com/click/here.pl%3fz2496384957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960729&HITNO=0&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960729&THISHREF=http://c.moreover.com/click/here.pl%3fz2496384957%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Preventing infectious complications in patients with chronic lymphocytic leukemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959038&HITNO=1&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959038&THISHREF=http://c.moreover.com/click/here.pl%3fz2495604056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959038&HITNO=1&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959038&THISHREF=http://c.moreover.com/click/here.pl%3fz2495604056%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHemonctoday: Preventing infectious complications in patients with chronic lymphocytic leukemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959037&HITNO=2&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959037&THISHREF=http://c.moreover.com/click/here.pl%3fz2495604013%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959037&HITNO=2&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959037&THISHREF=http://c.moreover.com/click/here.pl%3fz2495604013%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHemonctoday: GSK and Genmab obtain EU positive opinion for leukemia drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956207&HITNO=3&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956207&THISHREF=http://c.moreover.com/click/here.pl%3fz2494436172%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956207&HITNO=3&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956207&THISHREF=http://c.moreover.com/click/here.pl%3fz2494436172%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: GSK and Genmab obtain EU positive opinion for leukemia drug - Zib...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955953&HITNO=4&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955953&THISHREF=http://c.moreover.com/click/here.pl%3fz2494332927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955953&HITNO=4&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955953&THISHREF=http://c.moreover.com/click/here.pl%3fz2494332927%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: EMEA says yes to Genmab's blood cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955509&HITNO=5&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955509&THISHREF=http://c.moreover.com/click/here.pl%3fz2494061586%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955509&HITNO=5&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955509&THISHREF=http://c.moreover.com/click/here.pl%3fz2494061586%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBio Spectrum Asia: ::: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955054&HITNO=6&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955054&THISHREF=http://c.moreover.com/click/here.pl%3fz2493628802%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955054&HITNO=6&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955054&THISHREF=http://c.moreover.com/click/here.pl%3fz2493628802%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Arzerra (ofatumumab) receives positive opinion for conditional approval in Europe for refractory chronic lymphhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954844&HITNO=7&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954844&THISHREF=http://c.moreover.com/click/here.pl%3fz2493299095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954844&HITNO=7&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954844&THISHREF=http://c.moreover.com/click/here.pl%3fz2493299095%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954216&HITNO=8&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954216&THISHREF=http://c.moreover.com/click/here.pl%3fz2492557311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954216&HITNO=8&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954216&THISHREF=http://c.moreover.com/click/here.pl%3fz2492557311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: CHMP recommends conditional marketing authorisation for ofatumumab in EU to treat CLLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952287&HITNO=9&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952287&THISHREF=http://c.moreover.com/click/here.pl%3fz2490706932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952287&HITNO=9&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952287&THISHREF=http://c.moreover.com/click/here.pl%3fz2490706932%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951155&HITNO=10&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951155&THISHREF=http://c.moreover.com/click/here.pl%3fz2490038967%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951155&HITNO=10&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951155&THISHREF=http://c.moreover.com/click/here.pl%3fz2490038967%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTech Divas: GlaxoSmithKline (GSK) (JOBS), Genmab A/S (GEN.CO) Win EU Backing for Leukaemia Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950831&HITNO=11&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950831&THISHREF=http://c.moreover.com/click/here.pl%3fz2489844962%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950831&HITNO=11&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950831&THISHREF=http://c.moreover.com/click/here.pl%3fz2489844962%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Win EU Backing for Leukaemia Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950112&HITNO=12&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950112&THISHREF=http://c.moreover.com/click/here.pl%3fz2489464384%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950112&HITNO=12&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950112&THISHREF=http://c.moreover.com/click/here.pl%3fz2489464384%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditional Approval in Europe for Refractory Chronic Lhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948585&HITNO=13&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948585&THISHREF=http://c.moreover.com/click/here.pl%3fz2488689071%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948585&HITNO=13&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948585&THISHREF=http://c.moreover.com/click/here.pl%3fz2488689071%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Arzerra(TM) (Ofatumumab) Receives Positive Opinion for Conditiona...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948313&HITNO=14&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948313&THISHREF=http://c.moreover.com/click/here.pl%3fz2488519052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948313&HITNO=14&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fludarabine_Phosphate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948313&THISHREF=http://c.moreover.com/click/here.pl%3fz2488519052%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: